The first demonstration in Italy of the One Lambda™ HybriType™ HLA Plus Typing Flex kit has been successfully completed. This new NGS solution enables 11-loci HLA typing through hybrid capture technology, with a fast and streamlined workflow.
During the demo, the additional panel for 7 non-classical HLA loci and the optional ABO panel were also tested, allowing for a comprehensive evaluation of the product’s capabilities.
Lagitre’s Field Application Specialists, Giuseppe Tortorici and Valentina Viganò, supported by the One Lambda – A Thermo Fisher Scientific Brand team, led the sessions, which concluded with excellent results and a high level of satisfaction among all participants.
With this new NGS solution—soon to be CE-IVDR marked—Lagitre further strengthens its molecular portfolio, expanding the range of solutions available to support the needs of HLA laboratories and looking ahead with enthusiasm to a future full of new and exciting opportunities.